Foresite Capital

company

Investments

Number of Investments
Number of Lead Investments
31
8
Foresite Capital has made 31 investments. Their most recent investment was on Mar 8, 2022, when DNAnexus, Inc raised
Date Company Name Round Money Raised Industry Lead Investor
Mar 8, 2022 DNAnexus Series H — Bioinformatics —
Jan 6, 2022 Eikon Therapeutics Series B — Biotechnology —
Sep 9, 2021 Mammoth Biosciences Series D — Biotechnology —
Jun 29, 2021 Element Biosciences Series C — Biotechnology —
Jun 28, 2021 HealthVerity Series D — Health Care —
May 11, 2021 Aetion Series C — Analytics —
May 5, 2021 Eikon Therapeutics Series A — Biotechnology —
Nov 25, 2020 SomaLogic Series A — Biotechnology —
Nov 4, 2020 Mammoth Biosciences Series C — Biotechnology Yes
Jun 10, 2020 Cue Series C — Health Care —
Jun 9, 2020 DNAnexus Series G — Bioinformatics —
Jan 11, 2020 PACT Pharma Series C — Biotechnology —
Jan 9, 2020 Element Biosciences Series B — Biotechnology —
Nov 21, 2019 Genapsys Series C — Bioinformatics Yes
Aug 9, 2019 ORIC Pharmaceuticals Series D — Biotechnology —
Jun 18, 2019 Element Biosciences Series A — Biotechnology Yes
Apr 3, 2019 HealthVerity Series C — Health Care Yes
Feb 6, 2019 DNAnexus Series F — Bioinformatics —
Feb 21, 2018 ORIC Pharmaceuticals Series C — Biotechnology —
Jan 2, 2018 DNAnexus Series E — Bioinformatics Yes
Nov 13, 2017 Arcus Biosciences Series C — Biotechnology —
Sep 8, 2017 Replimune Group Series B — Biotechnology Yes
Sep 1, 2016 Arcus Biosciences Series B — Biotechnology —
Feb 17, 2016 10X Genomics Series C — Biotechnology —
Jan 19, 2016 Twist Bioscience Series D — Biotechnology —
Dec 2, 2015 ORIC Pharmaceuticals Series B — Biotechnology —
Sep 1, 2015 Intellia Therapeutics Series B — Biotechnology —
Jun 22, 2015 Ardelyx Post-IPO Equity — Biotechnology —
Jun 9, 2015 Twist Bioscience Series C — Biotechnology —
Dec 12, 2014 10X Genomics Series B — Biotechnology Yes
Jul 31, 2013 Karyopharm Therapeutics Series B — Health Care Yes